EP1019730A1 - STREIFENTEST ZUR $i(IN-VITRO)-ALLERGIEDIAGNOSTIK - Google Patents

STREIFENTEST ZUR $i(IN-VITRO)-ALLERGIEDIAGNOSTIK

Info

Publication number
EP1019730A1
EP1019730A1 EP98928264A EP98928264A EP1019730A1 EP 1019730 A1 EP1019730 A1 EP 1019730A1 EP 98928264 A EP98928264 A EP 98928264A EP 98928264 A EP98928264 A EP 98928264A EP 1019730 A1 EP1019730 A1 EP 1019730A1
Authority
EP
European Patent Office
Prior art keywords
test
allergens
strip
allergodip
allergen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP98928264A
Other languages
German (de)
English (en)
French (fr)
Inventor
Rüdiger WAHL
Oliver Cromwell
Helmut Fiebig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of EP1019730A1 publication Critical patent/EP1019730A1/de
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Definitions

  • the invention relates to a strip test for in vitro allergy diagnostics
  • IgE immunoglobulin E
  • In-vitro allergy diagnostics are becoming increasingly important in addition to in-vivo allergy diagnostics, which include, for example, skin, prick, intracutaneous and provocation tests, since the allergen spectrum is constantly increasing and in-vivo testing in many cases due to side effects is not feasible for the patient.
  • IgE immunoglobulin E
  • IgE immunoglobulin E
  • the invention relates to a strip test for in-vitro diagnosis for the assessment of specific IgE, characterized in that the test can be carried out both with whole blood and with serum.
  • the invention further relates to a strip test for in-vitro diagnosis for the assessment of specific IgE in sera and / or whole blood, characterized in that each stick is coated with a positive, a negative control and at least nine different allergens.
  • the strip test is used to assess specific IgE in whole blood or sera from allergy sufferers and can also be used in the veterinary area in addition to the human area.
  • the evaluation is preferably carried out visually by comparison with a color card.
  • the coloring of the allergen pads on the respective test strips is compared with a given color scale.
  • the color intensity is the indicator for the findings of the allergy diagnosis.
  • a typical strip test preferably includes 9 allergens, a negative and a positive control.
  • a complete test preferably contains different allergy test strips from different areas. These include, for example, grasses / cereals / herbs (G / G / K), animals / feathers / mites (T / F / M), trees (B), mushrooms (P), food (NM), screening (S) [Phadiatop ].
  • allergen spectrum is listed in the table below.
  • allergens of a special kind such as those found in roasted coffee, certain woods, latex etc.
  • Tree pollen grasses / cereals / herbs (G / G / K)
  • a commercial test of the present invention includes, for example
  • Inhalation allergen test strips Food allergen test strips Cross-reactivity allergen test strips and Mediterranean allergen test strips.
  • Allergodip TM The test strips according to the invention are referred to as Allergodip TM.
  • the above-mentioned exemplary composition of such an Allergodip test system in relation to the allergens to be tested can look as follows:
  • test system Other typical components of the test system are also patient color cards, test glass tubes with markings, test stands, conjugate, substrate, disposable pipettes and a regulation for performing and evaluating the test.
  • the conjugate is preferably AP-anti-IgE
  • the substrate is preferably AP-purple IgE or BM-purple IgE.
  • the test is preferably carried out at room temperature.
  • the test can also be carried out in the form of a 1-day and a 2-day test.
  • the main difference between the two tests is the duration of incubation with conjugate and substrate.
  • the test can also be performed with whole blood or with serum made from whole blood.
  • the individual test strips are preferably produced by bromine cyan activation, as is also known from allergen pane testing.
  • BrCN-activated sheets of paper are used to make the Allergodip.
  • the BrCN activation of the paper sheets was based on the allergen disk activation, whereby quantities and volumes were significantly reduced.
  • Cellulose paper is activated with BrCN.
  • the allergens are covalently coupled to the activated papers.
  • One allergen is coupled for each BrCN activated paper sheet (A4).
  • 4 mm wide strips are cut and glued onto a plastic strip (A4).
  • the plastic strips are e.g. 9 different allergens, a positive and a negative control glued.
  • the A4 plastic strip is cut into 4 mm wide plastic strips (Allergodips) that are approx. 7 cm long.
  • the allergen test strips are preferably produced in such a way that strips 4 mm wide are cut from the allergen-linked sheets. These strips are glued to each other on a polystyrene plate, approx. 30 cm long and 8 cm wide, using an adhesive tape on both sides. The different allergen strips are glued on top of each other and pressed on firmly. The polystyrene plates so glued with allergen strips are now added overnight using a specially developed press (using a torque wrench)
  • Allergodip strips
  • the strips are stored in tubes with 10-piece drying plugs, labeled and stored at -20 ° C. They are stable for at least 2 years under these conditions.
  • the polystyrene plate is also color-coded at the top to indicate which stripes are involved, e.g. trees. Every Allergodip has a different color.
  • Another object of the invention is a method for the detection of specific IgE in whole blood or sera, which is characterized in that at least the following steps are carried out in succession:
  • test can be carried out in the form of a 1-day or 2-day test:
  • the Allergodip is incubated in a 6.5 mm x 7 cm test tube with the serum for 30 minutes at room temperature. The strip is then washed in an ultrasonic bath for 2 minutes.
  • the strip is incubated with AP-Anti-IgE for 2 hours at room temperature.
  • the strip is then washed in an ultrasonic bath for 2 minutes.
  • the strip is incubated with substrate for 1.5 hours at room temperature.
  • the strip is dried with filter paper and the color reaction is assessed against a color card (possibly a densitometer).
  • the Allergodip is placed in a test tube containing the serum for 3 hours
  • the Allergodip is incubated with AP-Anti-IgE overnight at room temperature.
  • the strip is incubated with substrate for 1.5 hours at room temperature.
  • the strip is dried with filter paper and the color reaction is assessed against a color card (possibly a densitometer).
  • the 1-day test is divided into 3 allergen classes and the overnight test is divided into 4 classes.
  • Conjugate AP-Anti-IgE conjugate is used as conjugate.
  • AP-purple is used as the substrate.
  • BM purple can be used. Washing solution
  • a 0.9% NaCl solution is preferably used as the washing solution + 1% TWEEN 20 + 0.05% NaN 3 .
  • the washing solution is preferably diluted accordingly as a 1:15 concentrate.
  • Allergodip e.g. an ultrasonic bath, calibrated test tube, holder for Allergodip, stand for the test tube, disposable pipettes and a color card.
  • Ultrasonic bath washing can be replaced by washing under the tap.
  • Calibrated test tube tubes (1.5 ml) are preferably used to specify how much serum + reagents have to be pipetted.
  • the tubes should be placed in plastic or plexiglass stands.
  • the Allergodip can be washed in an ultrasonic bath, which is filled with the washing solution.
  • studies have shown that washing under the tap is also possible.
  • a special holder consisting of a plexiglass pane into which grooves for the holder clamps are milled.
  • a holder for the strips should also be used for washing under the tap.
  • the Allergodip is evaluated using a color card that is adapted to the colors that correspond to the 1 or 2-day test.
  • the color card enables a classification from class 0 - 4.
  • the Allergodip is offered as a 1 and 2 day test.
  • a patient card is preferably used to document the results.
  • the card gives the allergen composition again and is color coded individually for each test strip.
  • the invention furthermore relates to the use of the strip test for in vitro allergy diagnosis in the human and veterinary field.
  • the strip test can be used to detect inhalation allergens, food allergens, cross-reactivity allergens or Mediterranean allergens and to diagnose the associated allergies.
  • absorbent matrices that are usually used for such tests can be used as reagent papers.
  • the use of filter paper is the most common, but other absorbent cellulose or plastic products can also be used.
  • the absorbent carriers, preferably filter paper, are impregnated in a manner known per se with impregnation solutions which contain the reagents necessary for the determination of chlorine.
  • the soaked and dried papers can be processed into square or rectangular zones, which in turn are applied in a known manner to the carrier film, e.g. Plastic films, paper or metal strips can be glued or sealed.
  • the adhesive area is limited to a fraction of the reagent paper area, e.g. to 10 to 20%.
  • the reagent papers can also be coated in strips before being impregnated
  • Foam formation in protein-containing solutions leads to uncontrollable denaturation of proteins. Foaming by vigorous shaking or stirring should therefore be avoided.
  • allergens are immobilized by forming a covalent bond.
  • allergen coupling solution 115 ml of allergen coupling solution are placed in an incubation dish. The bowl is moved so that the sheet is completely covered with allergen coupling solution.
  • test sheets or strips are freeze-dried for storage.
  • the allergen sheets are sealed individually, airtight and without buffer in a film tube and stored temporarily at -20 ° C.
  • the sheets or strips are freeze-dried without a buffer, individually in GT trays. 8 sheets of allergen can be dried in one pass. Freeze drying overnight is sufficient.
  • Patient serum is pipetted into the test glass tube up to the ring marker. Allergodip, the test strip, is placed in the serum. All allergen pads must be under liquid.
  • the conjugate is pipetted into a second test tube up to the ring marker.
  • the Allergodip is placed in the conjugate and added for 2 hours
  • the wash is carried out with the same wash buffer as before in an ultrasonic bath for 5 minutes.
  • the Allergodip is removed and dabbed briefly with filter paper, then the substrate is pipetted up to the ring marker in a third test tube and the Allergodip is placed in the substrate. Incubation takes place for 3 hours at 37 ° C in the incubator.
  • the Allergodip test strip is then removed from the tube, blotted with filter paper and the color reaction is read. The results are assessed by comparison with a color chart (1-day test - class 0 - 4).
  • Allergodip can be stuck on for documentation.
  • the color complex of the test strip is stable for at least one year at room temperature.
  • the patient serum is pipetted into the test glass tube up to the ring maker. Allergodip is placed in the serum. All allergen pads must be under liquid. The incubation is carried out for 3 hours at room temperature.
  • the Allergodip test strip is removed from the serum and hung in an ultrasonic bath filled with washing buffer using the fastening clip or a holder. All allergen pads must be covered with the wash buffer and washed in an ultrasonic bath for 2 minutes. Then the sticks are removed and dabbed briefly with filter paper.
  • the conjugate AP-A-IgE to ring marker is then pipetted into a second test tube and the test strip is placed in the conjugate. The incubation takes place over a period of 18 hours at room temperature.
  • test strip is removed and with a washing buffer
  • test strip (0.9% NaCl, 1% Tween 20, 0.5% NaN 3 , water) washed in an ultrasonic bath for 2 minutes. The test strip is then removed and blotted with filter paper. The AP-purple IgE substrate is then pipetted into another test tube and the test strip is incubated for 90 minutes at room temperature.
  • Allergodip test strip is removed, dried with filter paper and the color reaction is read and evaluated. The results are assessed by comparison with the Allergodip color chart. The Allergodip is stuck in the patient card for documentation.
  • the test is carried out in the same way as the 1-day test. All time intervals are retained. There were no differences in the serum test. The color reaction was clear and distinct and corresponded to that of the serum test.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP98928264A 1997-05-21 1998-05-14 STREIFENTEST ZUR $i(IN-VITRO)-ALLERGIEDIAGNOSTIK Ceased EP1019730A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19721151 1997-05-21
DE19721151A DE19721151C2 (de) 1997-05-21 1997-05-21 Streifentest zur in-vitro-Allergiediagnostik
PCT/EP1998/002850 WO1998053321A1 (de) 1997-05-21 1998-05-14 Streifentest zur in-vitro-allergiediagnostik

Publications (1)

Publication Number Publication Date
EP1019730A1 true EP1019730A1 (de) 2000-07-19

Family

ID=7830024

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98928264A Ceased EP1019730A1 (de) 1997-05-21 1998-05-14 STREIFENTEST ZUR $i(IN-VITRO)-ALLERGIEDIAGNOSTIK

Country Status (7)

Country Link
EP (1) EP1019730A1 (xx)
JP (1) JP2002514306A (xx)
DE (1) DE19721151C2 (xx)
HU (1) HUP0003843A2 (xx)
PL (1) PL192349B1 (xx)
TR (1) TR199902855T2 (xx)
WO (1) WO1998053321A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19857936C1 (de) * 1998-12-16 2001-03-22 Heiko Schwertner Verfahren zur Bestimmung von spezifischen Antikörpern, Proteinen oder kleinen Molekülen unter der Verwendung von Vollblut mit Hilfe von Festphasen
WO2002066602A2 (en) * 2001-01-03 2002-08-29 Heska Corporation Detection of allergen-specific ige
JP4578709B2 (ja) * 2001-03-28 2010-11-10 三菱化学メディエンス株式会社 複数項目同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ
EP1564556A1 (de) 2004-02-17 2005-08-17 DST Diagnostic Science & Technology GmbH Verfahren und Vorrichtung zur Bestimmung mehrerer Analyten mit simultaner interner Kontrolle
AU2009247267B2 (en) 2008-05-12 2014-11-06 Animal Allergy Clinical Laboratories Method for quantification of antigen-specific canine or human IgE
EP2309267A1 (de) * 2009-10-09 2011-04-13 Merck Patent GmbH Verfahren zur Herstellung eines Allergietestträgers für die In-vitro-Diagnostik
KR20140111192A (ko) * 2013-03-08 2014-09-18 (주)프로테옴텍 다중 진단용 병렬식 라인형 바이오칩

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941876A (en) * 1973-04-25 1976-03-02 Gte New Ventures Corporation In vitro method for determining allergic hypersensitivity
US4331650A (en) * 1980-07-18 1982-05-25 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
US4459360A (en) * 1981-10-05 1984-07-10 Mast Medical Industries, Ltd. Multiple-component binding assay system and method of making and using it
US4567149A (en) * 1983-03-17 1986-01-28 Mast Immunosystems, Ltd. Binding assay system and method of making and using same
AU3616684A (en) * 1983-11-10 1985-06-03 Ventrex Laboratories Inc. Multiple allergen-bearing matrixes useful for qualitative allergy screening
AU560779B2 (en) * 1985-01-24 1987-04-16 Quidel Assay for drugs of abuse
AU2087388A (en) * 1987-07-02 1989-01-30 In Vitro Technologies, Inc. Capillary device for immunoassay of multiple analytes
US4891321A (en) * 1987-10-21 1990-01-02 Hubscher Thomas T Apparatus for performing determinations of immune reactants in biological fluids
JPH08511621A (ja) * 1993-06-09 1996-12-03 クイデル コーポレイション 抗原特異的1段階検定
DE19526675A1 (de) * 1994-09-09 1996-03-14 Herbert Prof Dr Wiegandt Teststreifenanalyse zur Erfassung von autoallergen menschlichen Pathologien
SE9500184D0 (sv) * 1995-01-20 1995-01-20 Pharmacia Ab Analysmetod som utnyttjar biospecifika affinitetsreaktioner och märkt reaktant samt reagens att användas i föredragen utförandeform

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9853321A1 *

Also Published As

Publication number Publication date
PL336978A1 (en) 2000-07-31
HUP0003843A2 (en) 2001-03-28
PL192349B1 (pl) 2006-10-31
WO1998053321A1 (de) 1998-11-26
TR199902855T2 (xx) 2000-02-21
DE19721151A1 (de) 1998-11-26
DE19721151C2 (de) 2002-10-31
JP2002514306A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
EP0126450B1 (de) Partikel sowie Verfahren zum Nachweis von Antigenen und/oder Antikörpern unter Verwendung der Partikel
DE69627182T2 (de) Element zum sammeln und transportieren von zu analyserendem probenmaterial und verfahren zur bestimmung eines analyts
Anderson et al. A technique for the use of minute amounts of dried blood in the fluorescent antibody test for schistosomiasis
DE2031447A1 (de) Verfahren zur Prüfung von Zellproben
DE69027882T2 (de) Messung der Reaktivität von Lymphozyten gegenüber spezifischen Antigenen im Blut
EP1019730A1 (de) STREIFENTEST ZUR $i(IN-VITRO)-ALLERGIEDIAGNOSTIK
DE69928245T2 (de) Verfahren zur probenentnahme
DE68917273T2 (de) Testmethode und Gerät zur Bestimmung des gesamten Proteins.
DE19608129A1 (de) Selbstklebender Indikator
Brinkmann Expertisen an biologischen Spuren
DE3501826C2 (xx)
DE69028126T2 (de) Festephasentest zum Nachweis der periodentalen Krankheit in einem subgingivalem Fleck
EP0267356B1 (de) Verfahren und Testelement zum Auffinden von Zelläsionen
DE3872895T2 (de) Probenentnahmevorrichtung.
DE60008189T2 (de) DNS-spezifische Farbstoff verwendender Sterilisationsindikator
DE69333201T2 (de) Vorrichtung und Test zur Bestimmung eines Antigens oder eines Antikörpers in einer Testprobe
EP1078262A1 (de) Indikationsstreifen zum nachweis von antikörpern im blutserum
DE2440930A1 (de) Visuelles verfahren zur feststellung von syphilis und anderen treponemalen erkrankungen
EP1726960B1 (de) Träger und Verfahren zum Nachweis von Anti-Borrelia-Antikörpern sowie Testkit zur Verwendung in der Diagnostik von Lyme-Borreliose-Infektionen
EP1336093A1 (de) Testkit für gleichzeitige erfassung mehrerer rückstandsarten
DE4446698C2 (de) Mikrotiterplatte mit einem Mittel zur Anzeige des Befüllungszustandes, Herstellung einer Mikrotiterplatte und Verwendung eines pH-Indikators
WO1996008723A1 (de) Schnelltest zur differenzierung von erythrozytenmerkmalen
DE3738982A1 (de) Verfahren zur bestimmung von proteinen, proteinstrukturen und nukleinsaeuren aus koerperfluessigkeiten
DE29616373U1 (de) Teststreifen für analytische Nachweisverfahren
DE2206697C3 (de) Verfahren und Schnellreagenz zum Nachweis von Morphin und Morphinderivaten

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990925

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20030711

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20070506